Publication Date:
2015
abstract:
The present invention provides for a humanized anti-BAG3 antibody or a fragment thereof, pharmaceutical compositions comprising said antibody and its use as a medicament, in particular for use in the treatment of pancreatic tumours or other pathologies of an immune, inflammatory, neoplastic, cardiovascular and/or degenerative nature.
Iris type:
6.1 Brevetto
Keywords:
Bag-3, Pancreatic Cancer, Targeted Therapy
List of contributors: